Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M De Angelis

Showing results (141-150 of 153) with videos related to

Pageof 16
Sort By:
Journal of Endocrinological Investigation|June 21, 2024
Gut microbiota and fecal volatilome profile inspection in metabolically healthy and unhealthy obesity phenotypesF M Calabrese, V A Genchi, N Serale, et al.
Medicina Oral, Patologia Oral Y Cirugia Bucal|October 14, 2025
Radiological features of double and inverted mesiodens: a systematic review of the literature and presentation of two casesA Lo-Casto, V Panzarella, E Palizzolo, et al.
Acta Neurochirurgica. Supplement|January 26, 2017
Vagal Nerve Stimulation for Drug-Resistant Epilepsy: Adverse Events and Outcome in a Series of Patients with Long-Term Follow-UpR Morace, G Di Gennaro, P P Quarato, et al.
Neuroimage|May 14, 2013
Preclinical evaluation of [(18)F]JNJ42259152 as a PET tracer for PDE10AS Celen, M Koole, M Ooms, et al.
Journal of Global Antimicrobial Resistance|April 22, 2023
Ceftazidime/avibactam-resistant meropenem-susceptible KPC-producing Klebsiella pneumoniae: Analysis of cases and evaluation of in vitro activity of fosfomycin-containing combinationsA Oliva, D Al Ismail, G Arcari, et al.
Journal of Medicinal Chemistry|July 27, 2001
A rational approach to the design of selective substrates and potent nontransportable inhibitors of the excitatory amino acid transporter EAAC1 (EAAT3). new glutamate and aspartate analogues as potential neuroprotective agentsG Campiani, M De Angelis, S Armaroli, et al.
Diabetes, Nutrition & Metabolism|July 10, 2003
Prevalence of carotid stenosis in type 2 diabetic patients asymptomatic for cerebrovascular diseaseM De Angelis, L Scrucca, M Leandri, et al.
International Journal of Cancer|March 14, 2007
Chromosomal 20q gain in the DNA diploid component of aneuploid colorectal carcinomasPaula M De Angelis, Trond Stokke, Marzieh Beigi, et al.
Genomics|January 7, 1998
Construction of a 780-kb PAC, BAC, and cosmid contig encompassing the minimal critical deletion involved in B cell chronic lymphocytic leukemia at 13q14.3I Bouyge-Moreau, G Rondeau, H Avet-Loiseau, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 21, 2014
Simultaneous liver-pancreas transplantation for cystic fibrosis-related liver disease: a multicenter experienceR H J Bandsma, M A Bozic, J A Fridell, et al.
Pageof 16

Showing results (141-150 of 153) with videos related to

Sort By:
Pageof 16
Journal of Endocrinological Investigation|June 21, 2024
Gut microbiota and fecal volatilome profile inspection in metabolically healthy and unhealthy obesity phenotypesF M Calabrese, V A Genchi, N Serale, et al.
Medicina Oral, Patologia Oral Y Cirugia Bucal|October 14, 2025
Radiological features of double and inverted mesiodens: a systematic review of the literature and presentation of two casesA Lo-Casto, V Panzarella, E Palizzolo, et al.
Acta Neurochirurgica. Supplement|January 26, 2017
Vagal Nerve Stimulation for Drug-Resistant Epilepsy: Adverse Events and Outcome in a Series of Patients with Long-Term Follow-UpR Morace, G Di Gennaro, P P Quarato, et al.
Neuroimage|May 14, 2013
Preclinical evaluation of [(18)F]JNJ42259152 as a PET tracer for PDE10AS Celen, M Koole, M Ooms, et al.
Journal of Global Antimicrobial Resistance|April 22, 2023
Ceftazidime/avibactam-resistant meropenem-susceptible KPC-producing Klebsiella pneumoniae: Analysis of cases and evaluation of in vitro activity of fosfomycin-containing combinationsA Oliva, D Al Ismail, G Arcari, et al.
Journal of Medicinal Chemistry|July 27, 2001
A rational approach to the design of selective substrates and potent nontransportable inhibitors of the excitatory amino acid transporter EAAC1 (EAAT3). new glutamate and aspartate analogues as potential neuroprotective agentsG Campiani, M De Angelis, S Armaroli, et al.
Diabetes, Nutrition & Metabolism|July 10, 2003
Prevalence of carotid stenosis in type 2 diabetic patients asymptomatic for cerebrovascular diseaseM De Angelis, L Scrucca, M Leandri, et al.
International Journal of Cancer|March 14, 2007
Chromosomal 20q gain in the DNA diploid component of aneuploid colorectal carcinomasPaula M De Angelis, Trond Stokke, Marzieh Beigi, et al.
Genomics|January 7, 1998
Construction of a 780-kb PAC, BAC, and cosmid contig encompassing the minimal critical deletion involved in B cell chronic lymphocytic leukemia at 13q14.3I Bouyge-Moreau, G Rondeau, H Avet-Loiseau, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 21, 2014
Simultaneous liver-pancreas transplantation for cystic fibrosis-related liver disease: a multicenter experienceR H J Bandsma, M A Bozic, J A Fridell, et al.
Pageof 16